Rucaparib
- Status:
- Red
- Decision Date:
- June 2019
Comments
RED1: NICE TA611 - for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer. (Decision date - December 2019) Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
- 8. NHS England commissioned – to be used in line with NHSE commissioning intentions
search again